Prices delayed by at least 15 minutes | Print
Beximco Pharmaceuticals Limited (BXP)
GDR (EACH REPR 1 ORD BDT10)This share can be held in a Dealing accountISALifetime ISAJISASIPPand can be used with Dividend reinvestment
Company profile
Beximco Pharmaceuticals Ltd is engaged in manufacturing and marketing a wide range of generic pharmaceutical formulation products, life-saving intravenous fluids, therapeutic nutrition products, and Active Pharmaceutical Ingredients. It manufactures various pharmaceutical products including oral contraceptives, hormones, steroids, anti-histamine, anti-fibrinolytic, cardiac, musculoskeletal, respiratory, vitamin & mineral supplements, women's health products, and others. The products of the company are sold in domestic and international markets. Key revenue accrues from local sales.
Address
19 Dhanmondi R/A
Road No 7
Dhaka
BGD
1205
Telephone
+880 258611891
Forecast key dates
| Name | Key Date |
|---|---|
| Beximco Pharmaceuticals Ltd Third Quarter Earnings Results for 2025 | 2025-04-30T00:00:00 |
| Beximco Pharmaceuticals Ltd Second Quarter Earnings Results for 2025 | 2025-01-30T00:00:00 |
| Beximco Pharmaceuticals Ltd Annual General Meeting for 2024 | 2024-12-27T10:30:00 |
| Beximco Pharmaceuticals Ltd Annual Report for 2024 | 2024-12-13T00:00:00 |
| Beximco Pharmaceuticals Ltd First Quarter Earnings Results for 2025 | 2024-11-06T00:00:00 |
| Beximco Pharmaceuticals Ltd Fourth Quarter Earnings Results for 2024 | 2024-11-01T00:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| Beximco Pharmaceuticals Ltd Third Quarter Earnings Results for 2024 | 2024-04-30T00:00:00 |
| Beximco Pharmaceuticals Ltd Second Quarter Earnings Results for 2024 | 2024-01-30T00:00:00 |
| Beximco Pharmaceuticals Ltd Annual General Meeting for 2023 | 2023-12-28T10:30:00 |
| Beximco Pharmaceuticals Ltd Annual Report for 2023 | 2023-12-13T00:00:00 |
| Beximco Pharmaceuticals Ltd First Quarter Earnings Results for 2024 | 2023-11-06T00:00:00 |
| Beximco Pharmaceuticals Ltd Fourth Quarter Earnings Results for 2023 | 2023-11-01T00:00:00 |
| Beximco Pharmaceuticals Ltd Third Quarter Earnings Results for 2023 | 2023-05-02T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.